Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2223]

FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer

FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer

Pembrolizumab and lenvatinib receive positive EU CHMP opinions for two different types of cancer

Pembrolizumab and lenvatinib receive positive EU CHMP opinions for two different types of cancer

First worldwide personalized-medicine study using a functional test demonstrates clinical feasibility and efficacy of individualised therapy in leukaemia and lymphoma patients

First worldwide personalized-medicine study using a functional test demonstrates clinical feasibility and efficacy...

FDA recognises Memorial Sloan-Kettering database of molecular tumour marker information

FDA recognises Memorial Sloan-Kettering database of molecular tumour marker information

Study establishes the value of cardiovascular magnetic resonance imaging for suspected cardiac tumours

Study establishes the value of cardiovascular magnetic resonance imaging for suspected cardiac tumours

Inhibition of the aurora kinase a protein may help overcome lung cancer resistance to KRAS inhibition

Inhibition of the aurora kinase a protein may help overcome lung cancer resistance to KRAS inhibition

Scientists identify TNK1 as a new cancer-driving mechanism, develop new drug to treat it

Scientists identify TNK1 as a new cancer-driving mechanism, develop new drug to treat it

OVANORDEST: Moroccan cancer research looks to improve survival in women with ovarian cancer

OVANORDEST: Moroccan cancer research looks to improve survival in women with ovarian cancer

6 out of 10 patients in England with ‘red flag’ symptoms not given urgent cancer referral

6 out of 10 patients in England with ‘red flag’ symptoms not given urgent cancer referral

Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs

Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs

More from ecancer